谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Mosunetuzumab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed And/or Refractory Follicular Lymphoma after ≥2 Prior Therapies: 3-Year Follow-up from a Pivotal Phase II Study

Stephen J. Schuster,Laurie H. Sehn,Nancy L. Bartlett,Matthew Matasar,Sarit Assouline,Pratyush Giri,John Kuruvilla,Mazyar Shadman,Chan Y. Cheah,Sascha Dietrich,Keith Fay,Matthew Ku,Loretta Nastoupil,Michael C. Wei,Shen Yin,Iris To,Jiangeng Huang,Antonia Kwan,Elicia Penuel,L. Elizabeth Budde

Clinical Lymphoma Myeloma and Leukemia（2024）

引用 1|浏览0
关键词
IBCL,non-Hodgkin lymphoma,indolent lymphoma,follicular lymphoma,bispecific antibody
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要